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Abstract 
Chondrocytes are the main cells in the extracellular matrix of articular 
cartilage and possess a highly differentiated phenotype that is the hallmark of the 
unique physiological functions of this specialised load-bearing connective tissue. The 
plasma membrane of articular chondrocytes contains a rich and diverse complement 
of membrane proteins, known as the membranome, which defines the cell surface 
phenotype of the cells. The membranome is a key target of pharmacological agents 
and is important for chondrocyte function. It includes channels, transporters, 
enzymes, receptors, and anchors for intracellular, cytoskeletal and extracellular 
matrix proteins and other macromolecular complexes. The chondrocyte channelome, 
is a sub-compartment of the membranome and includes a complete set of ion 
channels and porins expressed in these cells. Many of these are multi-functional 
proteins with “moonlighting” roles, serving as channels, receptors and signalling 
components of larger molecular assemblies. The aim of this review is to summarise 
our current knowledge of the fundamental aspects of the chondrocyte channelome, 
discuss its relevance to cartilage biology and highlight its possible role in the 
pathogenesis of osteoarthritis (OA). Excessive and inappropriate mechanical loads, 
an inflammatory micro-environment, alternative splicing of channel components or 
accumulation of basic calcium phosphate crystals can result in an altered 
chondrocyte channelome function. Alterations in Ca2+ signalling may lead to 
defective synthesis of ECM macromolecules and aggravated catabolic responses in 
chondrocytes, which is an important and relatively unexplored aspect of the complex 
mechanism of OA development. 
 
 
Keywords: Osteoarthritis; Articular cartilage; Chondrocyte; Membranome; 
Channelome, Ion Channel 
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Highlights 
 
 The chondrocyte channelome, is a sub-compartment of the membranome and includes a 
complete set of ion channels and porins expressed in these cells 
 The chondrocyte channelome is relevant to cartilage biology and plays a role in the 
pathogenesis of osteoarthritis (OA) 
 Alterations in Ca2+ signalling may further lead to the defective synthesis of extracellular 
matrix and aggravated catabolic responses in OA 
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Introduction 
Chondrocytes are the primary resident cells in articular cartilage and as the 
primary architects of the tissue (1), they are responsible for the synthesis and 
maintenance of all extracellular matrix (ECM) macromolecules (2). Fully developed 
cartilage is hypocellular, avascular, aneural, and alymphatic (3) and nutrition derives 
predominantly from the joint microcirculation via synovial fluid (4). Chondrocytes are 
cytoplasmically isolated within the cartilage ECM and nutrient/waste exchange 
occurs mainly through diffusion, often over long distances (2, 5). Chondrocytes are 
unique in their ability to exist in a low oxygen tension micro-environment and most 
energy requirements are obtained through glycolysis rather than oxidative 
phosphorylation (2). Even though chondrocytes possess fully functional mitochondria 
and all the enzymatic machinery for aerobic respiration, it is their hypoxic 
microenvironment that induces glycolytic pathways for ATP production (6). 
Chondrocytes must also exist under pressure and appear to react to cartilage 
deformation and to the changes in hydrostatic pressure, extracellular ionic 
composition and streaming potentials induced by mechanical load (7). Although the 
phenotype of chondrocytes is perfectly suited for their unique physiological functions, 
they possess poor potential for repair and regeneration, which predisposes cartilage 
to degenerative and arthritic conditions such as rheumatoid arthritis (RA) and 
osteoarthritis (OA), which pose a significant clinical burden. When the functional 
ECM is compromised, chondrocytes respond in an attempt to repair the damage but 
often the stimulated anabolic activity does not result in effective repair due to the 
extent and complexity of the ECM (8). ECM synthesized following injury and 
inflammation is often inferior and is unable to support the mechanical demands of 
the synovial joint. In addition to mechanical stress chondrocytes are exposed to a 
plethora of oxidants, pro-inflammatory cytokines, chemokine and catabolic factors in 
arthritic joints. The stress associated with being exposed to these factors promotes 
senescence, impairs autophagy and promotes cell death (9). This is why 
chondrocytes are intimately involved in OA, the most prevalent disease of synovial 
joints (10). Therefore, developing therapeutic strategies that support the anabolic 
activities of chondrocytes is an important area of research in orthopaedics and 
rheumatology. 
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The plasma membrane contains a rich complement of membrane proteins, 
which defines the cell surface phenotype of the cells, also known as the active 
surfaceome (11, 12) or membranome (13). Membrane proteins play crucial roles in 
many physiological and pathological processes, particularly in immune and cancer 
cells. Membrane proteins are also important for cartilage biology and chondrocyte 
function. They serve as ion, water and osmolyte channels, ion and molecular 
transporters, enzymes, receptors, and anchors for intracellular, cytoskeletal and 
ECM proteins and molecular complexes (14, 15). All living cells display electrical 
properties and possess a membrane potential. However, it is only muscle and nerve 
cells that are considered, by convention, to be “excitable”, whereas chondrocytes are 
cytoplasmically isolated and therefore “non-excitable”. Despite being non-excitable 
cells, the membranome of chondrocytes contains a diverse collection of channels 
that form the chondrocyte channelome, a concept that we introduced back in 2010 
(16). The chondrocyte channelome appears to be as complex as one might expect to 
find in excitable cells, although, in the case of chondrocytes, the function of the 
channelome is still poorly understood (Figure 1). Emerging evidence suggests that 
the membrane potential, conductance and capacitance are altered in disease and 
this implicates the channelome in OA. 
The aim of this review article is to summarise our current knowledge of the 
chondrocyte channelome and its relevance to cartilage biology and OA and extend 
this to the clinically relevant overlap between OA and cardiovascular disease. We 
provide an overview of current research on the chondrocyte channelome and 
highlight its relation to the chondrocyte proteome and membranome and focus on ion 
channels that are pathophysiologically relevant in OA. The chondrocyte channelome 
is important for understanding fundamental aspects of chondrocyte biology and has 
additional potential as a target for novel and pre-existing pharmacological and 
biological agents. The chondrocyte channelome is also a potential source of novel 
biomarkers as some membrane proteins are targets of proteases that may cleave 
membrane and channel proteins, resulting in cleavage products that may be 
released into the synovial fluid and some of these may potentially be detectable as 
biomarkers in synovial fluid and serum. The chondrocyte channelome is also likely to 
be involved in communication with cells in subchonrral bone and synovium plus 
other connective tissue and inflammatory cells in the joint. Since many channels are 
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“moonlighting” proteins (i.e. proteins that can perform more than one function) this 
dramatically expands the functional complexity of the chondrocyte channelome, 
implicating it in functions way beyond “channel activity”. 
 
Ionic and Osmotic Environment of Chondrocytes 
Research done in our laboratories and the laboratories of a number of other 
groups over the last two decades has focused on the role of sodium transport 
systems in chondrocytes. The reason for this is very simple. The cation content of 
cartilage is high due to the dense concentration of fixed negative charges on 
proteoglycans and glycosaminoglycans in the cartilage ECM. Therefore, 
chondrocytes exist in an unusual ionic and osmotic microenvironment (17). Their 
extracellular ionic environment is different from that of most cells, with extracellular 
Na+ being 250-350 mM and extracellular osmolality ranging from 350 to 450 mOsm 
depending on the joint studied and the depth and thickness of the cartilage. The high 
extracellular [Na+] creates a steep inward gradient for Na+ entry into chondrocytes, 
bringing sharply into focus the important physiological role of sodium channels and 
Na,K-ATPase in these cells (18). 
 
Epithelial Sodium Channels and Na,K-ATPase 
We were the first group to demonstrate the presence of the epithelial sodium 
channel (ENaC), previously undescribed in chondrocytes (19). We have shown that 
human chondrocytes express α and β subunits of ENaC and the abundance of these 
subunits is altered in arthritic chondrocytes. In cartilage tissue derived from 
rheumatoid arthritis (RA) patients the quantity of α and β subunits is significantly 
higher than in control (healthy) cartilage samples. On the other hand, ENaC α and β 
subunits are absent in the chondrocytes of cartilage derived from OA patients. These 
early observations indicated that some channels in the channelome are directly 
influenced by inflammatory and disease processes. 
Na,K-ATPase, also known as the “sodium pump”, is the membrane-
embedded transport system that maintains the intracellular concentrations of Na+ 
and K+ ions, against steep inward and outward electrochemical gradients and ATP 
provides energy for this exchange in a phosphorylation-dephosphorylation cycle, 
known as the Albers-Post cycle. This exchange is responsible for consuming up to 
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45% of the ATP supply in excitable cells. However, the percentage used by the 
Na,K-ATPase in chondrocytes has not been estimated. Na,K-ATPase is a 
heterodimeric protomer composed of an α and β subunit and optionally a third 
subunit, γ, belonging to the FXYD family of proteins. This is a family of small 
membrane proteins that share a 35-amino acid signature sequence domain, 
beginning with the amino acid sequence PFXYD and containing 7 invariant and 6 
highly conserved amino acids. FXYD proteins are often found to be associated with 
the α and β containing protomer (20, 21). Interestingly, the γ subunits and the FXYD 
proteins also exhibit channel forming properties by themselves. The α subunit 
contains the binding sites for sodium, potassium and other ions (20) (22) and 
regulatory and pharmacological ligands so far described (cardenolides, bufenolides 
(23)). Four α (α1 to 4) isoforms, three β (β1 to 3) isoforms and seven FXYD have 
been, so far, described. α and β isoforms associate promiscuously, any α can form 
quaternary structure with any β giving rise to isozymes of differentially specific kinetic 
parameters (24) (i.e. ion affinity, catalytic efficiency) leading to substantial 
physiological, developmental and pharmacological differences (23). Chondrocytes 
express multiple α and β subunits including α1, α2, α3, β1, β2 and β3 isoforms in a 
differential fashion according to developmental stages and pathologies (19) or cell 
line cultures (25). In chondrocytes derived from RA and OA joints changes in the 
ionic and osmotic environment alters sodium and potassium content in the ECM and 
chondrocytes respond to these changes by altering the active isozyme types present 
in the plasma membrane (19), in order to maintain the intracellular milieu within 
physiological conditions. Na,K-ATPase therefore plays an important role in ionic 
homeostasis in chondrocytes, but its expression in chondrocytes remains to be 
explored in congenital skeletal diseases and in metabolic diseases, including type II 
diabetes, hemochromatosis, alkaptonuria, Ehlers-Danlos syndrome and other 
genetic diseases that implicate sodium transport. 
 
Voltage-Dependent (Activated) Calcium Channels 
Voltage-dependent calcium channels (VDCCs) enable a rapid elevation of 
cytosolic Ca2+ levels and are important for Ca2+ signalling in chondrocytes, especially 
during skeletal development. VDCCs have been classified into the structurally and 
functionally related families of CaV1, CaV2, and CaV3 (26). During chondrogenesis 
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VDCCs functionally co-localise with β1 integrins, Na,K-ATPase and epithelial sodium 
channels in mechanoreceptor complexes in differentiating mouse limb bud-derived 
chondrocytes (27). CaV1.2 and 3.2 channel subunits were detected in chondrocytes 
in developing murine embryos and the same L-type Ca2+ channels were also 
identified in the ATDC5 chondrogenic cell line (28). VDCCs contribute to the 
elevation of cytosolic Ca2+ concentration by insulin-like growth factor-1 in mature 
articular chondrocytes (29).  
Ca2+ influx initiated via VDCCs is necessary for signalling pathways regulating 
ECM synthesis in electrically stimulated articular chondrocytes (30). The involvement 
of VDCCs has been demonstrated during in vitro chondrogenesis of micromass 
cultures established from distal limb buds of 4-day-old chicken embryos; chondrifying 
cells exhibited large Ca2+ transients by exposure to high concentrations of 
extracellular K+ (31), implicating the function of VDCCs. Examination of α1 subunit 
expression profiles in chicken micromass cultures identified members of L-type 
(CaV1.2 and CaV1.3); R-type (CaV2.3); and T-type (CaV3.1, CaV3.2, and CaV3.3) 
VDCCs (32). L-type VDCCs play important roles in generating Ca2+ influx for 
oscillations and treatment with nifedipine (10 μM) disrupted the regular pattern of 
repetitive calcium transients. Furthermore, inhibiting VDCC function with nifedipine 
abrogated chondrogenesis and almost completely inhibited cell proliferation (32). 
Although the above studies demonstrated the presence of functional α1 subunits in 
mature or differentiating chondrocytes, CaV3.2 was the first α1 subunit identified as 
essential for tracheal chondrogenesis in mice. In mice lacking CaV3.2 channels, 
Sox9 expression was attenuated, accompanied by disturbed tracheal cartilage 
formation (33). CaV3.2 channels were also found to be involved in signalling 
pathways triggering mechanical load-induced OA. Mice lacking CaV3.2 α1 subunit 
exhibited significantly lower focal articular cartilage damage than age-matched 
controls (34). More work is required to investigate VDCC changes in chondrocytes in 
early stages of OA and compare expression levels to later stages of OA progression. 
 
Ligand-Gated Ca2+ Entry Pathways - Purinergic Receptors 
Articular chondrocytes express a wide range of both P1 and P2 receptors 
including A1, A2A and A2B, as well as different subtypes of P2X (P2X1, P2X2, P2X3, 
P2X4, P2X7) and P2Y (P2Y1, P2Y2, P2Y4, P2Y6) receptors (35), (36). In a migratory 
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chondroprogenitor cell population (CPC), the mRNA and protein expression of P2X 
(P2X1, P2X4, P2X5, P2X6 and P2X7, but not P2X2 and P2X3) and all P2Y receptors 
have been observed and the functionality of P2Y1, P2Y2, P2Y4, as well as P2X4 and 
P2X6 receptor subtypes have been confirmed (37). Micromass cell cultures respond 
to extracellular ATP by elevating intracellular Ca2+ levels mainly at the time of 
chondroblast formation, and administration of ATP to the culture medium stimulated 
chondrogenesis (38). The presence of many purinoreceptors, i.e. P2X1, P2X4, P2X5 
and P2X7, as well as P2Y1, P2Y2, P2Y3, P2Y4 and P2Y5 has been demonstrated 
using western blotting in cells of differentiating micromass cultures, the receptor 
responsible for the rise of Ca2+ concentration evoked by extracellular ATP is believed 
to be the P2X4 receptor (38). Intracellular ATP oscillations, acting via P2X4 receptors, 
play a role in pre-chondrogenic condensation (39) and mediate the action of 
morphogens such as fibroblast growth factor (FGF) and sonic hedgehog (Shh) (40). 
Purinergic signalling was also reported to be involved in foetal articular cartilage 
repair in rat embryos in vivo (41). P2 purinergic receptors activated by extracellular 
ATP mediate strain-induced mechanotransduction through primary cilia in 
chondrocytes (42). The role of P1 and P2 receptors in OA is less clear and further 
work is needed to understand the involvement of purinergic signalling in 
chondrocytes in OA. 
 
N-methyl-D-aspartate receptors (NMDAR) 
L-glutamate activates both ionotropic (iGluR) and metabotropic (mGluR) 
receptors. Ionotropic glutamate receptors are ligand-gated cation channels and are 
classified as either alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA) receptors or kainate and N-methyl-D-aspartate receptors (NMDAR), the 
latter being primarily permeable to Ca2+ (43). Heterotetrameric NMDARs are 
comprised of two obligatory NR1 subunits and two subunits of four NR2 (NR2A, 
NR2B, NR2C or NR2D) and/or two NR3 (NR3A or NR3B) subunits (44). NR1, NR2D 
and NR3A NMDAR subunits have been shown to be constitutively expressed in 
developing chondrocytes (45) and mature articular chondrocytes (46) and are active 
components of mechanotransduction pathways (47). NR2D-containing NMDARs 
have also been shown to be important for chondrocyte proliferation (48). Thus far, 
Page 10 of 24
Ac
ce
pte
d M
an
us
cri
pt
 10
there is no published evidence for any direct or mechanistic involvement of 
glutamate signalling and NMDAR in OA. 
 
Transient Receptor Potential (TRP) Channels 
Transient receptor potential (TRP) channels play prominent roles in regulating 
the intracellular Ca2+ concentration in non-excitable cells. Mammalian TRP channels 
are conventionally divided into 6 subfamilies: canonical (TRPC), vanilloid (TRPV), 
melastatin (TRPM), ankyrin (TRPA), mucolipin (TRPML), polycystin (TRPP), and 
TRPN (“no mechanoreceptor potential C”) (44). Functioning as non-selective cation 
channels, members of the TRP subfamilies regulate many basic physiological 
processes including nociception, temperature, mechano- and osmosensation. 
TRP channels appear to be involved in OA. Articular chondrocytes isolated 
from knee joints of OA patients express various TRP ion channels (49). 
Differentiating micromass cultures have been found to express a wide range of 
TRPV ion channels (50). TRPA1 mediates acute inflammation and is a potential drug 
target in OA (51). The resting membrane potential in chondrocytes is at least partially 
regulated by TRPV5 (52) and also mediates Ca2+ influx and inhibits chondrocyte 
autophagy in an OA model (53). TRPV6 may act as a chondroprotective factor in OA 
as TRPV6 knockout mice exhibited severe osteoarthritic changes, including cartilage 
fibrillation, eburnation and loss of proteoglycans (54). Amongst TRP channels, the 
involvement of TRPV4 in chondrocyte physiology seems to be crucial. TRPV4 is an 
osmotically active ion channel and it is an important component of chondrocyte 
mechanotransduction pathways (55), (56), (57). TRPV4 is a positive regulator of 
Sox9 and pharmacological activation was shown to induce Sox9 reporter activity 
(58). A large number of mutations in TRPV4 have been linked to skeletal dysplasias, 
possibly via increasing follistatin production, which inhibits BMP signalling, leading to 
skeletal malformations (59). 
 
Ca2+ Release from Internal Stores and Store-Operated Ca2+ Entry (SOCE) 
Ca2+ released from intracellular Ca2+ stores (primarily from the ER) is a main 
source of cytosolic Ca2+ besides influx from the extracellular space across the 
plasma membrane. Although the existence of store-operated calcium pathways, the 
Page 11 of 24
Ac
ce
pte
d M
an
us
cri
pt
 11
primary Ca2+ entry to non-excitable cells (via Ca2+ release-activated Ca2+ channels 
or CRAC) has long been known, the identification of the molecules that orchestrate 
SOCE took almost 20 years (60). STIM1 is a Ca2+ sensor protein located in the ER 
membrane possessing an EF-hand domain that activates SOCE upon Ca2+ store 
depletion, whereas the homologue STIM2 is mainly involved in the maintenance of 
basal cytosolic and ER Ca2+ levels. Upon store depletion, STIM1 redistributes to 
sub-plasma membrane puncta, where it co-localizes with Orai1 (or Orai2/Orai3) to 
form the basic subunit required for SOCE. The close apposition of the ER and 
plasma membrane at the STIM1–Orai1 clusters enables SERCA pumps to rapidly 
and efficiently refill the ER Ca2+ stores (60). The first study to show the functional 
expression of STIM1/STIM2 and Orai1 in chondrogenic cells revealed that inhibition 
of SOCE combined with ER calcium store depletion abolished chondrocyte 
differentiation and severely diminished proliferation (32). Functional CRAC channels 
have also been detected in chondrocyte cell lines (61) and in chondrogenic 
progenitor cells derived from OA cartilage (37). 
 
The Chondrocyte Channelome in OA 
As highlighted in the introduction section, OA represents the most common 
form of a range of degenerative joint diseases that involve active processes by which 
cartilage and the surrounding tissues (i.e. synovium, peri-articular connective tissues 
and subchondral bone) respond pathologically to environmental factors. OA is now 
considered as being far more inflammatory than a disease of simple “wear and tear”. 
However, mechanical loading remains one of the major risk factors in the 
aetiopathogenesis of OA (62). Nevertheless, under physiologic conditions, moderate 
physical activity reduces the risk of cartilage deterioration (63), while mechanical 
stimuli can improve growth and properties of engineered cartilage tissue (64). 
One of the earliest means of chondrocyte response to extracellular 
mechanical input is a transient increase in intracellular Ca2+ levels, occurring within 
seconds to minutes (65). At least three types of ion channels that are regulated by 
different physical signals, including TRPV4 (osmotic and mechanical stress), T-type 
VDCCs (electrical potential), and mechanical sensitive ion channels (mechanical 
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loading) have been recently demonstrated to play critical roles in controlling the 
intracellular Ca2+ responses of in situ chondrocytes in the loaded cartilage (66). Ca2+ 
influx via voltage-operated calcium channels and store-operated calcium entry were 
both reported to regulate intracellular calcium oscillations in chondrogenic cells (26, 
32). 
A positive correlation between Ca2+ signalling and matrix synthesis was 
observed under mechanical load, implying its significant role in 
mechanotransduction-related anabolic processes (67)while in an altered biochemical 
and/or biomechanical setting mechanical factors can lead to OA development (62). 
Furthermore, joint immobilization has been shown to prevent the development of 
murine OA and revealed the highly mechanosensitive nature of the protease 
ADAMTS-5 expression in vivo (68). There is accumulating evidence to demonstrate 
that alterations in intracellular Ca2+ oscillations are associated with modifications in 
cartilage ECM synthesis which might be implicated in OA development (44). One of 
the causes for chondrocyte degradation is an increase in Ca2+ signalling that occurs 
during OA, inhibition of Ca2+ channels could serve as favourable therapeutic targets 
for OA (69). The pro-inflammatory cytokine interleukin 1β (IL-1β) has been shown to 
modify Ca2+ signalling in chondrocytes (70, 71). Application of a combination of pro-
inflammatory cytokines including IL-1β, tumour necrosis factor α (TNF-α) plus insulin 
induced a smaller increase in intracellular Ca2+, while hypotonic shock produced a 
larger Ca2+ increase in chondrocytes from healthy cartilage compared to 
chondrocytes from OA cartilage, highlighting the need for Ca2+ handling for effective 
adaptation to changes in tonicity even though basal Ca2+ was similar in both types of 
cells (72). Both IL-1β (73) and TNF-α (74) were shown to modulate activation and 
permeability of voltage gated ion channels in neurons. Although such information is 
not available for chondrocytes, similar activities of inflammatory factors also seem 
very likely. The available data implies altered calcium signalling responses to distinct 
loading characteristics and the inflammatory environment of the ECM in OA. 
Deletion of TRPV4 4 in mice results in severe OA-like changes, including age 
and male sex-dependent cartilage fibrillation, eburnation, and loss of proteoglycans 
(75). Loss of chondrocyte TRPV4 has been shown to prevent age-related OA 
development but not mechanical load dependent OA following destabilization of the 
medial meniscus (76). 
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Many conditions may influence activity of ion channels and Ca2+ signalling 
during mechanotransduction, which can in turn alter the biosynthetic response. 
Application of static or dynamic loading, location (zone) of cartilage, intensity, 
duration of loading, load-induced desensitization or application of superimposed 
vibrations of different amplitudes and frequency bandwidths may modulate the 
intracellular calcium levels and switch the cellular responses towards the domination 
of catabolic events characteristic of OA (67, 77, 78). Noteworthy, the intracellular pH 
and Ca2+ response of chondrocytes from OA cartilage was different from the 
response of chondrocytes isolated from healthy cartilage and were dependent on 
extracellular calcium (72). 
 
Crystals Modulate Calcium Signalling in OA 
Basic calcium phosphate crystals accumulate in OA cartilage and give rise to 
numerous manifestations, including OA-like lesions and destructive arthroplasties 
(79). Intra-articular injection of calcium phosphate crystals elicited synovial 
inflammation and cartilage degradation, suggesting a direct pathogenic role in OA 
(80). Basic calcium phosphate crystals induced proteoglycan loss and IL-6 
expression in human cartilage explants (81). In a murine OA model related to 
changes in mechanical loading, increasing deposits of basic calcium phosphate 
crystals were observed around the joint and correlated with cartilage degradation 
and IL-6 expression (81). It has been demonstrated that basic calcium phosphate 
crystals can induce variation in intracellular Ca2+ content and oscillations in 
chondrocytes which are mediated through voltage- and non-voltage-dependent Ca2+ 
channels (82). The changes in intracellular Ca2+ content, induced by basic calcium 
phosphate crystals, were shown to play a pivotal role in catabolic effects on articular 
cartilage (82). 
Modulation of other channels (other than Ca2+) can alter levels of intracellular 
Ca2+ levels and contribute to the development of OA (83). ClC-7 knockdown or the 
hypo-osmotic culture conditions, resulting in reduced expression of ClC-7, decreased 
the acid-sensitive currents in a human chondrocyte cell line, which resulted in 
enhanced cell death (84). Thus, downregulation of ClC-7 channels during the hypo-
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osmotic stress that accompanies OA progression might appear to be one of 
components of its aetiology. 
Expression of a newly identified splice variant in the large conductance Ca2+-
activated K+ (BK) channels, BK channel α subunit (BKαΔe2), was detected in 
several tissues from humans and mice (85). This splice variant negatively regulates 
functional expression of BK channels and modulates essential cellular functions, 
such as cyclooxygenase-2 gene expression in human chondrocytes. 
 
Conclusions 
In summary, our knowledge of the chondrocyte is gradually expanding, albeit 
slowly, compared to the most of other cells. The study of channels is chondrocytes is 
clinically relevant. Excessive or inappropriate mechanical loads, an inflammatory 
micro-environment, alternative splicing of channel components or accumulation of 
basic calcium phosphate crystals can all result in an altered chondrocyte 
channelome and changes in membrane potential and conductance. These 
alterations in Ca2+ signalling may further lead to the defective synthesis of ECM 
macromolecules and lead to aggravated catabolic responses, which is an important 
and relatively unexplored concept of the complex mechanism of OA development. 
Proteomics has highlighted changes in proteins involved in developmental processes 
in OA (86), and some of these proteins are membrane proteins. Preliminary 
quantitative proteomic analyses carried out in our laboratory have revealed major 
changes in the chondrocyte membranome in response to treatment with pro-
inflammatory cytokines such as IL-1β and TNF-α (Matta and Mobasheri, unpublished 
observations). These cytokines downregulate adhesion molecules (integrins and 
cadherins), intracellular and extracellular chaperones and growth factor receptors but 
they upregulate receptors for pro-inflammatory cytokines, potentially enhancing the 
sensitivity of cellular responses to inflammatory signalling. They also increase the 
abundance of vascular adhesion molecules and zinc transporters that are important 
for accumulation of zinc, an important co-factor for matrix metalloproteinases. These 
changes effectively alter the phenotype of chondrocytes, promoting the development 
of a senescent secretory phenotype. 
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Many clinically used cardiovascular drugs are also ion channel inhibitors. 
These are abundantly and protractedly used to treat cardiovascular and neurological 
diseases and can reach chondrocytes in the joint via the synovial and subchondral 
microcirculation. A preliminary and pilot study has suggested that certain calcium 
antagonists may exert beneficial clinical side effects for OA patients 
(87)[BED(oVM1].However, the long-term effects of calcium antagonists on chondrocytes 
and cartilage are unknown and further studies need to be carried out to understand 
the effects of modulating calcium channels in chondrocytes. From a purely 
physiological and cell biological perspective, future studies should also focus on 
further exploration of the roles of connexins, water, osmolytes and putative gas 
channels in chondrocytes and other cells in the synovial joint in health and disease 
(i.e. models that recapitulate the inflammatory microenvironment as well as 
integrating the inappropriate mechanical loads seen in OA joints). We need to fully 
understand the roles of channels in chondrocytes from healthy joints (i.e. normal 
chondrocyte function and physiology) before we make any attempt to make 
deductions or assumptions about their pathophysiological involvement in OA and 
other joint diseases.  
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Figure Legends 
 
Figure 1. Schematic representation of the chondrocyte channelome. This figure 
shows some of the major constituents of the chondrocyte channelome identified to 
date, with special emphasis on Ca2+ channels. Some of these channels show altered 
expression and function in pathological conditions such as OA. Abbreviations: K[Ca] 
- Calcium-activated potassium channels; TRP - transient receptor potential; VDCCs - 
voltage-dependent calcium channel; P1/P2 - purinergic receptors; SOCE - store-
operated Ca2+ channel entry; SMOC - second messenger-operated channels; 
VDSCs - voltage-dependent sodium channels; NSCC, non-selective cation channel; 
ENaC - epithelial sodium channel; NMDAR - N-methyl- D-aspartate receptors; NCX - 
sodium, calcium exchanger; PMCA - plasma membrane calcium ATPase; ClC - 
chloride channel; Na,K ATPase – sodium pump. 
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